Skip to content

Clinical trials

Phase 3 Uterine Cervical Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 3 Country / region: Spain Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20092
20151
20171
20182
20201
20211
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
European Organisation for Research and Treatment of Cancer - EORTC2
Advenchen Laboratories, LLC1
GlaxoSmithKline1
Grupo Español de Investigación en Cáncer de Ovario1
Institut Claudius Regaud1
National Cancer Institute (NCI)1
Seagen, a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms13
Endometrial Neoplasms2
Papillomavirus Infections2
Vaginal Neoplasms2
Adenocarcinoma1
Carcinoma1
Carcinoma, Adenosquamous1
Condylomata Acuminata1
Fallopian Tube Neoplasms1
Infections1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.